Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-01-07 @ 11:28 AM
Study NCT ID:
NCT00862134
Status:
TERMINATED
Last Update Posted:
2013-01-10
First Post:
2009-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Proacta, Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PR104-2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None